V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004735 | 220010961 | null | 59.8 | Curative (C) | 2014-04-10 | 2014-04-10 | Trial Unspecified | Y | N | 220026688 | TRIAL |
| 220004736 | 220010961 | 0 | null | Palliative (P) | 2017-06-01 | 2017-06-07 | Cytarabine Low Dose | N | N | 220026688 | CYTARABINE |
| 220004737 | 220010961 | 1.76 | 80.1 | null | 2013-01-23 | 2013-01-26 | AML17 TRIAL | 01 | N | 220026688 | AML17 TRIAL |
| 220004738 | 220010961 | 1.7 | null | Disease modification (D) | 2013-08-10 | 2013-08-17 | Cytarabine Low Dose | 2 | N | 220026688 | CYTARABINE |
| 220004739 | 220010961 | 1.79 | null | Disease modification (D) | 2017-10-26 | 2017-11-02 | Cytarabine Low Dose | N | N | 220026688 | CYTARABINE |
| 220004740 | 220021701 | 1.76 | 60 | Disease modification (D) | 2016-10-09 | 2016-10-10 | Cytarabine Low Dose | N | N | 220026696 | CYTARABINE |
| 220004741 | 220001877 | null | 59.4 | Palliative (P) | 2017-05-06 | 2017-05-12 | CYTARABINE | 2 | null | 220026697 | CYTARABINE |
| 220004742 | 220001878 | 1.82 | 42 | Curative (C) | 2016-01-16 | 2016-02-07 | AML17 TRIAL | 1 | N | 220026698 | AML17 TRIAL |
| 220004743 | 220001878 | null | 77.4 | Curative (C) | 2013-09-23 | 2013-09-23 | Trial Unspecified | 1 | null | 220026698 | TRIAL |
| 220004744 | 220015850 | 1.68 | 79 | Curative (C) | 2015-01-02 | 2015-01-02 | LI-1 TRIAL | Y | N | 220026700 | TRIAL |
| 220004745 | 220018688 | 1.52 | 62.4 | Curative (C) | 2017-07-12 | 2017-07-12 | AML17 TRIAL | 01 | N | 220026704 | AML17 TRIAL |
| 220004746 | 220018688 | 1.56 | 108.4 | Curative (C) | 2013-10-23 | 2013-10-31 | Trial Unspecified | 1 | null | 220026704 | TRIAL |
| 220004747 | 220001879 | 1.7 | 94 | Disease modification (D) | 2017-10-07 | 2017-10-12 | Cytarabine low (10to20mg/m2) IV/SC | 02 | null | 220026709 | CYTARABINE |
| 220004748 | 220001879 | 1.77 | 101 | Palliative (P) | 2014-07-29 | 2014-08-02 | Cytarabine Low Dose | 2 | N | 220026709 | CYTARABINE |
| 220004749 | 220001879 | 1.8 | 57.2 | null | 2015-03-26 | 2015-03-27 | Trial Unspecified | Y | N | 220026709 | TRIAL |
| 220004750 | 220001879 | 1.75 | 70.5 | null | 2013-05-06 | 2013-05-07 | Trial Unspecified | 01 | N | 220026709 | TRIAL |
| 220004751 | 220001879 | 1.6 | 80 | Disease modification (D) | 2013-10-22 | 2013-10-22 | AML17 TRIAL | 1 | N | 220026709 | AML17 TRIAL |
| 220004752 | 220001879 | 1.75 | 73.4 | Palliative (P) | 2013-12-29 | 2013-12-30 | Cytarabine Low Dose | 2 | N | 220026709 | CYTARABINE |
| 220004753 | 220001879 | 0 | 50.1 | Curative (C) | 2015-12-06 | 2015-12-18 | AML17 TRIAL | 2 | N | 220026709 | AML17 TRIAL |
| 220004754 | 220001879 | 1.71 | 88.3 | Disease modification (D) | 2017-06-29 | 2017-06-30 | Cytarabine Low Dose | 02 | null | 220026709 | CYTARABINE |
| 220004755 | 220001879 | 1.7 | 73.8 | Curative (C) | 2013-08-27 | 2013-08-28 | AML17 TRIAL | 01 | N | 220026709 | AML17 TRIAL |
| 220004756 | 220001880 | null | 95.3 | Curative (C) | 2017-10-30 | 2017-10-31 | AML17 TRIAL | Y | N | 220026721 | AML17 TRIAL |
| 220004757 | 220001880 | 1.84 | 77.3 | Curative (C) | 2017-03-27 | 2017-03-27 | LI-1 TRIAL | 1 | N | 220026721 | TRIAL |
| 220004758 | 220001880 | 1.5 | 87 | Curative (C) | 2017-11-23 | 2017-11-23 | Trial Unspecified | Y | null | 220026721 | TRIAL |
| 220004759 | 220001880 | null | 68 | null | 2015-11-17 | 2015-11-20 | Cytarabine Low Dose | Y | N | 220026721 | CYTARABINE |
| 220004760 | 220001881 | 1.8 | 77 | Disease modification (D) | 2017-12-29 | 2017-12-29 | LI-1 TRIAL | 1 | N | 220026733 | TRIAL |
| 220004761 | 220010965 | 1.8 | 82.1 | Curative (C) | 2015-11-17 | 2015-11-17 | Trial Unspecified | 1 | N | 220026734 | TRIAL |
| 220004762 | 220001882 | null | 0 | Palliative (P) | 2016-01-23 | 2016-01-23 | Cytarabine Low Dose | 02 | N | 220026739 | CYTARABINE |
| 220004763 | 220001882 | null | 7 | Curative (C) | 2015-08-03 | 2015-08-03 | Cytarabine Low Dose | N | N | 220026739 | CYTARABINE |
| 220004764 | 220001883 | 1.82 | 60.2 | Curative (C) | 2016-04-30 | 2016-05-06 | AML17 TRIAL | 99 | null | 220026743 | AML17 TRIAL |
| 220004765 | 220001883 | null | 106 | Palliative (P) | 2015-02-25 | 2015-02-25 | CYTARABINE | 02 | N | 220026743 | CYTARABINE |
| 220004766 | 220001883 | 1.83 | 93 | Palliative (P) | 2015-10-25 | 2015-10-25 | Trial Unspecified | 01 | null | 220026743 | TRIAL |
| 220004767 | 220001883 | 1.78 | 50.6 | Curative (C) | 2014-08-14 | 2014-08-15 | AML17 TRIAL | N | N | 220026743 | AML17 TRIAL |
| 220004768 | 220001884 | 1.75 | 64 | Palliative (P) | 2013-09-18 | 2013-09-24 | Cytarabine Low Dose | 02 | N | 220026747 | CYTARABINE |
| 220004769 | 220001884 | null | 0 | Palliative (P) | 2013-03-31 | 2013-04-11 | CYTARABINE | Y | N | 220026747 | CYTARABINE |
| 220004770 | 220015854 | 1.7 | 68.4 | Palliative (P) | 2014-08-06 | 2014-08-06 | CYTARABINE | 02 | N | 220026749 | CYTARABINE |
| 220004771 | 220015854 | 1.49 | 51.5 | Curative (C) | 2017-04-30 | 2017-05-03 | Cytarabine Low Dose | N | N | 220026749 | CYTARABINE |
| 220004772 | 220015854 | 1.82 | 81.4 | null | 2013-12-07 | 2013-12-12 | AML17 TRIAL | null | N | 220026749 | AML17 TRIAL |
| 220004773 | 220001885 | 0 | null | Palliative (P) | null | 2014-11-28 | Cytarabine Low Dose | N | N | 220026752 | CYTARABINE |
| 220004774 | 220010969 | null | 82.3 | Curative (C) | 2016-02-20 | 2016-02-20 | AML17 TRIAL | null | null | 220026753 | AML17 TRIAL |
| 220004775 | 220010969 | 1.76 | 91 | Curative (C) | 2013-11-20 | 2013-11-26 | AML17 TRIAL | Y | N | 220026753 | AML17 TRIAL |
| 220004776 | 220010969 | null | null | Disease modification (D) | 2015-08-14 | 2015-08-14 | CYTARABINE | N | N | 220026753 | CYTARABINE |
| 220004777 | 220001886 | 1.57 | 58.5 | Curative (C) | 2016-08-13 | 2016-08-14 | Trial Unspecified | N | N | 220026762 | TRIAL |
| 220004778 | 220001887 | 1.57 | 56.5 | Curative (C) | 2016-02-28 | 2016-02-28 | AML17 TRIAL | 1 | null | 220026763 | AML17 TRIAL |
| 220004779 | 220010970 | null | null | Palliative (P) | null | 2014-01-12 | Cytarabine Low Dose | null | null | 220026764 | CYTARABINE |
| 220004795 | 220001889 | 1.78 | 90 | Curative (C) | 2017-08-07 | 2017-08-09 | AML17 TRIAL | Y | N | 220026797 | AML17 TRIAL |
| 220004796 | 220010972 | null | 57.3 | null | 2014-11-29 | 2014-11-30 | CYTARABINE | N | N | 220026800 | CYTARABINE |
| 220004797 | 220001890 | 1.85 | 55.4 | Curative (C) | 2016-02-06 | 2016-02-07 | AML17 TRIAL | 1 | N | 220026802 | AML17 TRIAL |
| 220004798 | 220001890 | null | null | Palliative (P) | null | 2016-02-03 | Cytarabine Low Dose | null | null | 220026802 | CYTARABINE |
| 220004799 | 220001890 | 1.85 | 84.8 | Curative (C) | 2017-10-03 | 2017-10-03 | Trial Unspecified | Y | N | 220026802 | TRIAL |